Human plasma hyaluronidase

Details Human plasma hyaluronidase Human plasma hyaluronidase

2006-09-12

2006-09-12

Prouty, Rebecca E. (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Hydrolase

C435S201000, C435S207000, C435S069600, C435S007920, C435S018000, C435S320100, C435S338000, C424S094620, C424S094610, C530S388260

Reexamination Certificate

active

07105330

ABSTRACT:
The invention is based on the discovery of methods for purification of an acid active hyaluronidase found in human plasma (hpHAse), including both biochemical and immunoaffinity purification methods. The method of immunoaffinity purification of the invention is based on the discovery of a method for identifying antibodies that specifically bind native hpHAse (anti-native hpHAse antibodies), and anti-native hpHAse antibodies identified by this screening method. The invention also features an assay for sensitive detection of HAse activity using biotinylated hyaluronic acid (bHA). Purification and characterization of hpHAse lead to the inventors' additional discovery that hpHAse is encoded by the LuCa-1 gene, which gene is present in the human chromosome at 3p21.3, a region associated with tumor suppression. The invention additionally features methods of treating tumor-bearing patients by administration of hpHAse and/or transformation of cells with hpHAse-encoding DNA.

REFERENCES:
patent: 3945889 (1976-03-01), Mima et al.
patent: 5427779 (1995-06-01), Elsner et al.
patent: WO 96/31596 (1996-10-01), None
Afify et.al., Purification and characterization of human serum hyaluronidase, Arch. Biochem. Biophys. 305 (2): 434-441.
Northrup et al., (1973) “Development of the hyaluronidase Activity Assay As A Cancer Screening Test” Clin. Biochem. 6:220-228.
Afify et al., (1993) “Purification and Characterization of Human Serum Hyaluronidase” Arch. Biochem. Biophys. 305 (2) :434-441.
De Salegui et al., (1967) “A Comparison of Serum and Testicular Hyaluronidase” Arch. Biochem. Biophys. 121:548-554.
Fenger et al (1982) “Purification of Human Serum Hyaluronidase Using Chromatofocusing.” (J. Chromatogr. 240:173-179).
Fiszer-Szafarz et al., (1989) “Hyal-l, a Locus Determining Serum Hyaluronidase Polymorphism, in Chromosome 9 in Mice” Somat. Cell. Mol. Genet. 15:79-83.
Gabizon (1995) “Stealth Liposomes and Cancer Targeting: A Realistic Compromise in Drug Delivery.” (J. Liposome Res., 5:704-710).
Gregoriadis et al. (1993) “Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.” (Drugs, 45:15-28).
Johnstone et al. (1987) (Immunochemistry in Practice, Blackwell Scientific Publications, Oxford, pp. 30-31).
Kolarova et al., (1970) “Host-Tumour Relationship XXIX. Hyaluronidase Activity and Seromucoid Concentration in Blood Serum of Patients with Cancer” Neoplasma 17:641-648.
Natowicz et al., (1996) “Clinical and Biochemical Manifestations of Hyaluronidase Deficiency” N. Engl. J. Med. 335 (14):1029-1033.
Verma, I. M. et al. “Gene Therapy—promises, Problems and Prospects” (1997) Nature vol. 389, pp. 239-242.
Orkin, S. H. et al. “Report and Recommendations of The Panel to Assess The NIH Investment in Research on Gene Therapy” (1995).
Eck, S. L. et al “Gene-Based therapy” in The Pharmacological Basis of therapeutics, Goodman & Gilman's, McGraq-Hill, Ninth Edition, pp. 77-101, 1996.
Rozenberg, Y. et al. “Alternative Gene Delivery” S.T.P. Pharma Sci (2001) vol. 11, pp. 21-30.
Nishikawa, M. et al. “Nonviral Vectors in The New Millennium: Delivery Barrier in Gene Transfer” (2001) Hum Gene Ther vol. 12, pp. 861-870.
Balicki, D. et al. “Gene Therapy of Human Disease” (2002) Medicine vol. 81, pp. 69-86.
Csoka, T. B. et al. “Hyaluronidases in Tissue Invasion” (1997) Invasion and Metastasis vol. 17, No. 6, pp. 297-311.
Chang N. S. “Transforming Growth Factor-beta Protection of Cancer Cells Against Tumor Necrosis Factor Cytotoxicity is counteracted by Hyaluronidase” (1998) Int J Mol Med vol. 2, No. 6, pp. 653-659.
Lepperdinger, G. et al. “Hyal2—Less Active, But Nore Versatile?” (2001) Matrix Biol vol. 20, pp. 509-514.
Lin Ji et al. Expression of several genes in the human chromosome 3p21.3 homozygous detetion region by an adenovirus vector results in tumor suppressor activities in Vitro and in Vivo. Cancer Res. 62:2715-2720, 2002.

Affiliated with

Also associated with

Rating

Human plasma hyaluronidase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human plasma hyaluronidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human plasma hyaluronidase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3612225